Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

L Gibson

Showing results (711-720 of 986) with videos related to

Pageof 99
Sort By:
Pediatric Pulmonology|July 31, 2010
An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosisChristopher M Oermann, George Z Retsch-Bogart, Alexandra L Quittner, et al.
Annals of the American Thoracic Society|August 19, 2020
Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation TreatmentJonathan D Cogen, Anna V Faino, Frankline Onchiri, et al.
Neoplasia (New York, N.Y.)|July 6, 2006
Induction of the tumor-suppressor p16(INK4a) within regenerative epithelial crypts in ulcerative colitisEmma E Furth, Karen S Gustafson, Charlotte Y Dai, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 26, 2024
Perspectives of Canadian health leaders on the relationship between medical assistance in dying and palliative and end-of-life care services: a qualitative studyGilla K Shapiro, Eryn Tong, Rinat Nissim, et al.
Plos One|January 21, 2022
MOP and NOP receptor interaction: Studies with a dual expression system and bivalent peptide ligandsM F Bird, J McDonald, B Horley, et al.
Annals of the American Thoracic Society|March 15, 2022
Clinical Outcomes of Antipseudomonal versus Other Antibiotics among Children with Cystic Fibrosis without <i>Pseudomonas aeruginosa</i>Jonathan D Cogen, Anna V Faino, Frankline Onchiri, et al.
Chest|May 8, 2009
Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosisGeorge Z Retsch-Bogart, Alexandra L Quittner, Ronald L Gibson, et al.
BMC Public Health|March 12, 2010
Canadian survey on pandemic flu preparationsPaul Ritvo, Kumanan Wilson, J L Gibson, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 10, 2012
Feasibility of using pedometers to measure daily step counts in cystic fibrosis and an assessment of its responsiveness to changes in health stateBradley S Quon, Donald L Patrick, Todd C Edwards, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|February 8, 2012
Identifying effective behavioural models and behaviour change strategies underpinning preschool- and school-based obesity prevention interventions aimed at 4-6-year-olds: a systematic reviewC A Nixon, H J Moore, W Douthwaite, et al.
Pageof 99

Showing results (711-720 of 986) with videos related to

Sort By:
Pageof 99
Pediatric Pulmonology|July 31, 2010
An 18-month study of the safety and efficacy of repeated courses of inhaled aztreonam lysine in cystic fibrosisChristopher M Oermann, George Z Retsch-Bogart, Alexandra L Quittner, et al.
Annals of the American Thoracic Society|August 19, 2020
Effect of Concomitant Azithromycin and Tobramycin Use on Cystic Fibrosis Pulmonary Exacerbation TreatmentJonathan D Cogen, Anna V Faino, Frankline Onchiri, et al.
Neoplasia (New York, N.Y.)|July 6, 2006
Induction of the tumor-suppressor p16(INK4a) within regenerative epithelial crypts in ulcerative colitisEmma E Furth, Karen S Gustafson, Charlotte Y Dai, et al.
CMAJ : Canadian Medical Association Journal = Journal De L'Association Medicale Canadienne|February 26, 2024
Perspectives of Canadian health leaders on the relationship between medical assistance in dying and palliative and end-of-life care services: a qualitative studyGilla K Shapiro, Eryn Tong, Rinat Nissim, et al.
Plos One|January 21, 2022
MOP and NOP receptor interaction: Studies with a dual expression system and bivalent peptide ligandsM F Bird, J McDonald, B Horley, et al.
Annals of the American Thoracic Society|March 15, 2022
Clinical Outcomes of Antipseudomonal versus Other Antibiotics among Children with Cystic Fibrosis without <i>Pseudomonas aeruginosa</i>Jonathan D Cogen, Anna V Faino, Frankline Onchiri, et al.
Chest|May 8, 2009
Efficacy and safety of inhaled aztreonam lysine for airway pseudomonas in cystic fibrosisGeorge Z Retsch-Bogart, Alexandra L Quittner, Ronald L Gibson, et al.
BMC Public Health|March 12, 2010
Canadian survey on pandemic flu preparationsPaul Ritvo, Kumanan Wilson, J L Gibson, et al.
Journal of Cystic Fibrosis : Official Journal of the European Cystic Fibrosis Society|January 10, 2012
Feasibility of using pedometers to measure daily step counts in cystic fibrosis and an assessment of its responsiveness to changes in health stateBradley S Quon, Donald L Patrick, Todd C Edwards, et al.
Obesity Reviews : an Official Journal of the International Association for the Study of Obesity|February 8, 2012
Identifying effective behavioural models and behaviour change strategies underpinning preschool- and school-based obesity prevention interventions aimed at 4-6-year-olds: a systematic reviewC A Nixon, H J Moore, W Douthwaite, et al.
Pageof 99